RICHARD PAUL BRYCE Insider Trading $PBYI PUMA BIOTECHNOLOGY, INC.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for RICHARD PAUL BRYCE.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of RICHARD PAUL BRYCE. RICHARD PAUL BRYCE is SEE REMARKS in PUMA BIOTECHNOLOGY, INC. ($PBYI) and SR VP, CLINICAL RESEARCH & DEV in PUMA BIOTECHNOLOGY, INC. ($PBYI).

RICHARD PAUL BRYCE in PUMA BIOTECHNOLOGY, INC.

Trading Symbol: PBYI
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of RICHARD PAUL BRYCE: SEE REMARKS, SR VP, CLINICAL RESEARCH & DEV
Holdings: 121,662 shares
Current Value: $4,118,259
Latest Transaction: Apr 06 2021
$PBYI Market Capitalization: $1.37B
$PBYI Previous Close: $33.85

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of RICHARD PAUL BRYCE in PUMA BIOTECHNOLOGY, INC.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Apr 06 2021PBYIPUMA BIOTECHNOLOGY ...BRYCE RICHARD PAULSEE REMARKSSellS9.804264,176121,662122.1 K to 121.7 K (-0.35 %)
Mar 04 2021PBYIPUMA BIOTECHNOLOGY ...BRYCE RICHARD PAULSEE REMARKSSellS10.154224,283122,088122.5 K to 122.1 K (-0.34 %)
Feb 19 2021PBYIPUMA BIOTECHNOLOGY ...BRYCE RICHARD PAULSEE REMARKSOption ExerciseA12.0274,341893,57974,341
Feb 19 2021PBYIPUMA BIOTECHNOLOGY ...BRYCE RICHARD PAULSEE REMARKSGrantA0.0052,8460122,51069.7 K to 122.5 K (+75.86 %)
Feb 03 2021PBYIPUMA BIOTECHNOLOGY ...BRYCE RICHARD PAULSEE REMARKSSellS12.234155,07669,66470.1 K to 69.7 K (-0.59 %)
Dec 04 2020PBYIPUMA BIOTECHNOLOGY ...BRYCE RICHARD PAULSEE REMARKSSellS11.65921,07276,62776.7 K to 76.6 K (-0.12 %)
Oct 05 2020PBYIPUMA BIOTECHNOLOGY ...BRYCE RICHARD PAULSEE REMARKSSellS10.149192376,81676.9 K to 76.8 K (-0.12 %)
Sep 03 2020PBYIPUMA BIOTECHNOLOGY ...BRYCE RICHARD PAULSEE REMARKSSellS9.779087976,90777 K to 76.9 K (-0.12 %)
Aug 05 2020PBYIPUMA BIOTECHNOLOGY ...BRYCE RICHARD PAULSEE REMARKSSellS10.808692976,99777.1 K to 77 K (-0.11 %)
Jul 06 2020PBYIPUMA BIOTECHNOLOGY ...BRYCE RICHARD PAULSEE REMARKSSellS10.676607,04077,08377.7 K to 77.1 K (-0.85 %)
Jun 03 2020PBYIPUMA BIOTECHNOLOGY ...BRYCE RICHARD PAULSEE REMARKSSellS10.668994977,74377.8 K to 77.7 K (-0.11 %)
May 06 2020PBYIPUMA BIOTECHNOLOGY ...BRYCE RICHARD PAULSEE REMARKSSellS9.628985677,83277.9 K to 77.8 K (-0.11 %)
Apr 03 2020PBYIPUMA BIOTECHNOLOGY ...BRYCE RICHARD PAULSEE REMARKSSellS7.379167177,92178 K to 77.9 K (-0.12 %)
Apr 03 2020PBYIPUMA BIOTECHNOLOGY ...BRYCE RICHARD PAULSEE REMARKSSellS7.379167177,92178 K to 77.9 K (-0.12 %)
Feb 13 2020PBYIPUMA BIOTECHNOLOGY ...BRYCE RICHARD PAULSEE REMARKSOption ExerciseA12.3454,842676,75054,842
Feb 13 2020PBYIPUMA BIOTECHNOLOGY ...BRYCE RICHARD PAULSEE REMARKSGrantA0.0043,274078,10834.8 K to 78.1 K (+124.23 %)
Feb 04 2020PBYIPUMA BIOTECHNOLOGY ...BRYCE RICHARD PAULSEE REMARKSSellS8.0210584234,83434.9 K to 34.8 K (-0.30 %)
Dec 03 2019PBYIPUMA BIOTECHNOLOGY ...BRYCE RICHARD PAULSEE REMARKSSellS10.348385836,45536.5 K to 36.5 K (-0.23 %)
Nov 05 2019PBYIPUMA BIOTECHNOLOGY ...BRYCE RICHARD PAULSEE REMARKSSellS7.388864936,53836.6 K to 36.5 K (-0.24 %)
Oct 03 2019PBYIPUMA BIOTECHNOLOGY ...BRYCE RICHARD PAULSEE REMARKSSellS10.059191536,62636.7 K to 36.6 K (-0.25 %)
Sep 05 2019PBYIPUMA BIOTECHNOLOGY ...BRYCE RICHARD PAULSEE REMARKSSellS10.119596036,71736.8 K to 36.7 K (-0.26 %)
Sep 05 2019PBYIPUMA BIOTECHNOLOGY ...BRYCE RICHARD PAULSEE REMARKSSellS10.119596036,71736.8 K to 36.7 K (-0.26 %)
Aug 05 2019PBYIPUMA BIOTECHNOLOGY ...BRYCE RICHARD PAULSEE REMARKSSellS9.009484636,81236.9 K to 36.8 K (-0.25 %)
Jul 24 2019PBYIPUMA BIOTECHNOLOGY ...BRYCE RICHARD PAULSEE REMARKSSellS10.101,84118,58936,90638.7 K to 36.9 K (-4.75 %)
Jul 03 2019PBYIPUMA BIOTECHNOLOGY ...BRYCE RICHARD PAULSEE REMARKSSellS12.78891,13738,74738.8 K to 38.7 K (-0.23 %)
Jun 05 2019PBYIPUMA BIOTECHNOLOGY ...BRYCE RICHARD PAULSEE REMARKSSellS15.07881,32638,83638.9 K to 38.8 K (-0.23 %)
May 06 2019PBYIPUMA BIOTECHNOLOGY ...BRYCE RICHARD PAULSEE REMARKSSellS32.38852,75238,92439 K to 38.9 K (-0.22 %)
Apr 03 2019PBYIPUMA BIOTECHNOLOGY ...BRYCE RICHARD PAULSEE REMARKSSellS35.78883,14939,00939.1 K to 39 K (-0.23 %)
Mar 22 2019PBYIPUMA BIOTECHNOLOGY ...BRYCE RICHARD PAULSEE REMARKSSellS38.66883,40239,09739.2 K to 39.1 K (-0.22 %)
Mar 22 2019PBYIPUMA BIOTECHNOLOGY ...BRYCE RICHARD PAULSEE REMARKSSellS38.66883,40239,09739.2 K to 39.1 K (-0.22 %)
Feb 08 2019PBYIPUMA BIOTECHNOLOGY ...BRYCE RICHARD PAULSEE REMARKSOption ExerciseA27.7615,400427,50415,400
Feb 08 2019PBYIPUMA BIOTECHNOLOGY ...BRYCE RICHARD PAULSEE REMARKSGrantA0.009,900039,18529.3 K to 39.2 K (+33.81 %)
Feb 06 2019PBYIPUMA BIOTECHNOLOGY ...BRYCE RICHARD PAULSEE REMARKSSellS27.77892,47229,28529.4 K to 29.3 K (-0.30 %)
Jan 24 2019PBYIPUMA BIOTECHNOLOGY ...BRYCE RICHARD PAULSEE REMARKSSellS24.721,95948,42629,37431.3 K to 29.4 K (-6.25 %)
Jan 04 2019PBYIPUMA BIOTECHNOLOGY ...BRYCE RICHARD PAULSEE REMARKSSellS20.671,21025,01131,33332.5 K to 31.3 K (-3.72 %)
Jul 24 2018PBYIPUMA BIOTECHNOLOGY ...BRYCE RICHARD PAULSEE REMARKSSellS51.951,83695,38132,54334.4 K to 32.5 K (-5.34 %)
Feb 13 2018PBYIPUMA BIOTECHNOLOGY ...BRYCE RICHARD PAULSEE REMARKSOption ExerciseA60.8514,000851,90014,000
Feb 13 2018PBYIPUMA BIOTECHNOLOGY ...BRYCE RICHARD PAULSEE REMARKSGrantA0.009,000034,37943.4 K to 34.4 K (-20.75 %)
Jan 24 2018PBYIPUMA BIOTECHNOLOGY ...BRYCE RICHARD PAULSR VP, CLINICAL RES ...SellS92.751,860172,51525,37927.2 K to 25.4 K (-6.83 %)
Oct 02 2017PBYIPUMA BIOTECHNOLOGY ...BRYCE RICHARD PAULSR VP, CLINICAL RES ...Option ExerciseM11.3015,000169,50067,000
Oct 02 2017PBYIPUMA BIOTECHNOLOGY ...BRYCE RICHARD PAULSR VP, CLINICAL RES ...SellS120.0015,0001,800,00027,23942.2 K to 27.2 K (-35.51 %)
Oct 02 2017PBYIPUMA BIOTECHNOLOGY ...BRYCE RICHARD PAULSR VP, CLINICAL RES ...BuyM11.3015,000169,50042,23927.2 K to 42.2 K (+55.07 %)
Sep 08 2017PBYIPUMA BIOTECHNOLOGY ...BRYCE RICHARD PAULSR VP, CLINICAL RES ...Option ExerciseM11.3014,000158,20082,000
Sep 08 2017PBYIPUMA BIOTECHNOLOGY ...BRYCE RICHARD PAULSR VP, CLINICAL RES ...Option ExerciseM11.301,00011,30096,000
Sep 08 2017PBYIPUMA BIOTECHNOLOGY ...BRYCE RICHARD PAULSR VP, CLINICAL RES ...SellS100.1014,0001,401,40027,23941.2 K to 27.2 K (-33.95 %)
Sep 08 2017PBYIPUMA BIOTECHNOLOGY ...BRYCE RICHARD PAULSR VP, CLINICAL RES ...BuyM11.3014,000158,20041,23927.2 K to 41.2 K (+51.40 %)
Sep 08 2017PBYIPUMA BIOTECHNOLOGY ...BRYCE RICHARD PAULSR VP, CLINICAL RES ...SellS100.001,000100,00027,23928.2 K to 27.2 K (-3.54 %)
Sep 08 2017PBYIPUMA BIOTECHNOLOGY ...BRYCE RICHARD PAULSR VP, CLINICAL RES ...BuyM11.301,00011,30028,23927.2 K to 28.2 K (+3.67 %)
Jul 24 2017PBYIPUMA BIOTECHNOLOGY ...BRYCE RICHARD PAULSR VP, CLINICAL RES ...SellS95.20766627,23927.2 K to 27.2 K (-0.03 %)
Jul 24 2017PBYIPUMA BIOTECHNOLOGY ...BRYCE RICHARD PAULSR VP, CLINICAL RES ...SellS94.481,991188,11127,24629.2 K to 27.2 K (-6.81 %)
Jul 14 2017PBYIPUMA BIOTECHNOLOGY ...BRYCE RICHARD PAULSR VP, CLINICAL RES ...Option ExerciseM11.305,00056,50097,000
Jul 14 2017PBYIPUMA BIOTECHNOLOGY ...BRYCE RICHARD PAULSR VP, CLINICAL RES ...SellS87.105,000435,50029,23734.2 K to 29.2 K (-14.60 %)
Jul 14 2017PBYIPUMA BIOTECHNOLOGY ...BRYCE RICHARD PAULSR VP, CLINICAL RES ...BuyM11.305,00056,50034,23729.2 K to 34.2 K (+17.10 %)
Feb 21 2017PBYIPUMA BIOTECHNOLOGY ...BRYCE RICHARD PAULSR VP, CLINICAL RES ...Option ExerciseA37.3531,5001,176,52531,500
Jan 24 2017PBYIPUMA BIOTECHNOLOGY ...BRYCE RICHARD PAULSR VP, CLINICAL RES ...SellS33.242,29376,20829,23731.5 K to 29.2 K (-7.27 %)
Oct 14 2016PBYIPUMA BIOTECHNOLOGY ...BRYCE RICHARD PAULSR VP, CLINICAL RES ...GrantA0.0031,500031,53030 to 31.5 K (+105,000.00 %)
May 27 2016PBYIPUMA BIOTECHNOLOGY ...BRYCE RICHARD PAULSR VP, CLINICAL RES ...Option ExerciseA35.6141,2501,468,91341,250
Aug 04 2015PBYIPUMA BIOTECHNOLOGY ...BRYCE RICHARD PAULSR VP, CLINICAL RES ...Option ExerciseA87.8831,5002,768,22031,500
Jul 08 2015PBYIPUMA BIOTECHNOLOGY ...BRYCE RICHARD PAULSR VP, CLINICAL RES ...Option ExerciseM11.303,00033,900102,000
Jul 08 2015PBYIPUMA BIOTECHNOLOGY ...BRYCE RICHARD PAULSR VP, CLINICAL RES ...SellS110.033,000330,084303 K to 30 (-99.01 %)
Jul 08 2015PBYIPUMA BIOTECHNOLOGY ...BRYCE RICHARD PAULSR VP, CLINICAL RES ...BuyM11.303,00033,9003,03030 to 3 K (+10,000.00 %)
May 21 2015PBYIPUMA BIOTECHNOLOGY ...BRYCE RICHARD PAULSR VP, CLINICAL RES ...BuyP82.49282,310302 to 30 (+1,400.00 %)
May 21 2015PBYIPUMA BIOTECHNOLOGY ...BRYCE RICHARD PAULSR VP, CLINICAL RES ...BuyP87.35217520 to 2
Jul 10 2014PBYIPUMA BIOTECHNOLOGY ...BRYCE RICHARD PAULSR VP, CLINICAL RES ...Option ExerciseA65.6631,5002,068,29031,500
Jul 11 2013PBYIPUMA BIOTECHNOLOGY ...BRYCE RICHARD PAULSR VP, CLINICAL RES ...Option ExerciseA55.2036,7502,028,60036,750
Jun 28 2012PBYIPUMA BIOTECHNOLOGY ...BRYCE RICHARD PAULSR VP, CLINICAL RES ...Option ExerciseA11.30105,0001,186,500105,000

Page:   1